IDR Beta cell Heterogeneity

New Research Findings, Diabetes, IDR, IDO,

Rising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target

Research targeting the insulin-inhibitory receptor, called inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy. A novel study in mice with diet-induced obesity demonstrates that the knock-out of…

Gender Equality

Diabetes, IDR, IDO, IDM,

Striving for Optimal Healthcare

Sex-Specific Research

Fork with measuring tape around on pink background

Transfer, HI-MAG, IDO,

Science Has Named GLP-1 Drugs the Breakthrough of the Year

2023 has changed the way we treat obesity. A new class of drugs, mimicking a gut hormone called glucagon-like peptide-1 (GLP-1), is reshaping medicine and improving many people’s lives globally. GLP-1 drugs do not only induce significant weight loss,…

Das Bild zeigt in rot die Akkumulation von GIP im Hirnstamm nach einmaliger peripherer Injektion und in grün die dadurch bewirkte Aktivierung von Neuronen. in Zusammenhang mit der Publikation Liskiewicz et al. (2023): Glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via GABAergic neurons in mice. Nature Metabolism.

New Research Findings, Diabetes, IDO,

Understanding the Role of GIP in Managing Diabetes and Obesity

The increasing amount of patients with obesity and type 2 diabetes benefit greatly from the recently developed GIPR:GLP-1R co-agonists. These novel compounds lead to substantial weight loss, offering a revolutionary approach to patients worldwide.…

Matthias Tschöp receives Heinrich Wieland Price 2023

Awards & Grants, Diabetes, IDO,

"Reversing the Pandemic of Obesity and Diabetes"

Heinrich Wieland Prize for Matthias Tschöp: Breakthrough in the battle against obesity and diabetes

IDO, Institute for Diabetes and Obesity

Awards & Grants, Diabetes, IDO,

Regulation of Energy and Glucose Metabolism: Timo Müller Honored with Minkowski Prize Awarded by the EASD

Diabetes researcher Dr. Timo Müller was honored with the 58th Minkowski Prize awarded by the EASD for his distinction manifested by publications that contribute to the advancement of knowledge concerning diabetes.